We observed a significant effect for muscle pain at all three time points; for GHQ-12 at 2 and 6 months, and bordering significance at 3 months; for BIS, a significant effect at 2 months, near significance at 3 months; when a preliminary improvement in the control group was also observed, and near significance at 6 months.
1
—
—